Breaking News

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its new state-of-the-art Technology Centre in Hyderabad, marking a significant milestone in...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...

Johnson & Johnson Presents New Clinical Data Across Bipolar Mania, Depression and Schizophrenia

Johnson & Johnson announced the presentation of comprehensive new clinical and real-world data across its industry-leading neuropsychiatry portfolio...

Surat Gets Major Healthcare Boost as PM Modi Inaugurates ₹216 Crore ESIC Hospital

Prime Minister Narendra Modi has officially inaugurated a newly upgraded, state-of-the-art 220-bedded Employees’ State Insurance Corporation (ESIC) Hospital in Surat, Gujarat. The virtual dedication...

Lupin Teams up with Laboratorios ERN to launch Luforbec®️ PMDI in the Spanish Market

Lupin Limited (Lupin) the Mumbai based Indian pharma major on 08th June announced its strategic collaboration with LABORATORIOS ERN S.A. (ERN), a renowned Spanish pharmaceutical company, for the launch of Luforbec® (beclometasone/formoterol) 100/6, a fixed...

IPC Issues Drug Safety Alert Linking Clonidine to Hyponatremia Risk

The Indian Pharmacopoeia Commission (IPC), acting through the National Coordination Centre of the Pharmacovigilance Programme of India (NCC-PvPI), has officially issued a critical drug...

Novartis Strengthens Autoimmune Disease Portfolio with Key Highlights from EULAR 2026

Novartis AG concluded a defining presence at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress today at ExCeL London, presenting pivotal findings from 31...

AstraZeneca’s Ultomiris®️ Cuts Proteinuria by 43.4% in Phase – 3 Trial

Alexion, AstraZeneca Rare Disease, announced positive results from a prespecified interim analysis of the global Phase III I CAN trial. The data demonstrate...

Drug Control Raid in Howrah: Large Stock of Medicines Seized, Samples Sent for Testing

A multi-day operation by the Drug Control Department in Howrah has led to the seizure of a large quantity of medicines from a godown...